XSHE
300698
Market cap531mUSD
Sep 30, Last price
26.54CNY
Name
Wanma Technology Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 1997 and headquartered in Hangzhou, China, Wanma Technology Co., Ltd. focuses on the development, manufacturing, integration, and sale of telecommunications and healthcare information technology solutions. Its communications segment provides a comprehensive range of products, including mobile base station infrastructure, optical and fiber optic communication components, BBU enclosures, power distribution units, industry-specific offerings, and smart light pole systems. Within its medical information division, the company offers various mobile workstations for patient care, doctors, and billing, alongside intelligent operating room dressing management systems, clinic reporting tools, medical handheld devices (PDAs), information management platforms, and RFID products. These innovations serve critical sectors such as data centers, cloud computing infrastructure, communication networks, the healthcare industry, and transportation systems like high-speed rail and urban transit.
Key people
Xunhong Li
Deputy General Manager · since 2024
Zhengxiang Zhu
Deputy General Manager, Director · since 2022
Yahui Li
Secretary of the Board, Director · since 2025
Nan Yan
Vice Chairman of the Board, General Manager · since 2024
Shanshan Zhang
Director · since 2015
Heyang Zhang
Chairman of the Board · since 2023
Yanhua Zhu
Director · since 2024
Qingfang Zhu
Chief Financial Officer, Director · since 2024
Guanghua Song
Independent Director · since 2021
Huafeng Yan
Independent Director · since 2021
Meilian Zheng
Independent Director · since 2021
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||